Next Article in Journal
Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins
Previous Article in Journal
HIV Genetic Diversity and Drug Resistance
Previous Article in Special Issue
RNA Replicons - A New Approach for Influenza Virus Immunoprophylaxis
Article Menu

Export Article

Open AccessReview
Viruses 2010, 2(2), 532-546;

Developing Vaccines to Combat Pandemic Influenza

Division of Virology, National Institute for Biological Standards and Control, Health Protection Agency, Blanche Lane, South Mimms, Potters Bar, EN6 3QG, UK
Author to whom correspondence should be addressed.
Received: 25 November 2009 / Revised: 28 January 2010 / Accepted: 29 January 2010 / Published: 2 February 2010
(This article belongs to the Special Issue Influenza: Pandemics and Vaccinations)
Full-Text   |   PDF [202 KB, uploaded 12 May 2015]   |  


Influenza vaccine manufacturers require antigenically relevant vaccine viruses that have good manufacturing properties and are safe to use. In developing pandemic vaccine viruses, reverse genetics has been employed as a rational approach that can also be used effectively to attenuate the highly virulent H5N1 virus and at the same time place the H5 HA and N1 NA on a background of PR8, a virus that has been used over many decades to provide high yielding vaccine viruses. Reverse genetics has also been used successfully alongside classical reassorting techniques in the development of (swine flu) pandemic A(H1N1)v vaccine viruses. View Full-Text
Keywords: pandemic influenza vaccines; reverse genetics; H5N1 virus; H1N1v virus pandemic influenza vaccines; reverse genetics; H5N1 virus; H1N1v virus

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Robertson, J.S.; Engelhardt, O.G. Developing Vaccines to Combat Pandemic Influenza. Viruses 2010, 2, 532-546.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top